You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches
Dermatology
On demand events

ADVENT ON TOUR BILBAO | PRURIGO NODULAR: LA DELGADA LÍNEA AMARILLA

Una nueva escala de ADVENT ON TOUR en BILBAO sobre Prurigo Nodular.

On demand materials

Fisiopatología del prurigo nodular y carga de la enfermedad
Dermatology
expert video

Fisiopatología del prurigo nodular y carga de la enfermedad

Desarrollo clínico de nuevas terapias en el prurigo nodular
Dermatology
expert video

Desarrollo clínico de nuevas terapias en el prurigo nodular

Manejo terapéutico del prurigo nodular en vida real
Dermatology
expert video

Manejo terapéutico del prurigo nodular en vida real

Prurigo nodular: La delgada línea amarilla: Debate
Dermatology
expert video

Prurigo nodular: La delgada línea amarilla: Debate

Learning objectives

  • Papel de la inflamación tipo 2 en la fisiopatología del PN
  • Desarrollo clínico de nuevas terapias en el prurigo nodular
  • Manejo terapéutico del prurigo nodular en vida real
  • Fisiopatología del prurigo nodular y su manejo práctico

Description

No se pierda las videopíldoras de ADVENT ON TOUR BILBAO recorriendo la fisiopatología del Prurigo Nodular, el desarrollo clínico de nuevas terapias y el manejo terapéutico en vida real.

Tags
cytokinesdisease controlexpert insightsIL-13IL-4mechanism of diseasemultiple disease dimensionssymptomstype 2 inflammation
MAT-ES-2301174, MAT-ES-2301175, MAT-ES-2301176, MAT-ES-2301177, V1 05/2023

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: SpainChange country/region